1. CLINICAL OUTCOMES FROM VENETOCLAX BASED THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY B‐CELL LYMPHOMAS. (12th June 2019) Authors: Lewis, K.L.; Dowling, M.; Bavishi, K.; Øvlisen, A.K.; Hamad, N.; Choi, P.; Grigg, A.; P'Ng, S.; Filshie, R.; Ritchie, D.S.; Bilmon, I.; Prince, H.M.; Wolf, M.; Hertzberg, M.; Chuah, H.; El‐Galaly, T.C.; Tam, C.S.; Seymour, J.F.; Cheah, C.Y. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 535 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Feasibility of early discharge strategies for neutropenic fever: outcomes of a Victorian organisational readiness assessment and pilot. Issue 9 (4th September 2013) Authors: Lingaratnam, S.; Mellerick, A.; Worth, L. J.; Green, M.; Guy, S.; Kirsa, S.; Slavin, M.; Renwick, W.; Filshie, R.; Thursky, K. A. Journal: Internal medicine journal Issue: Volume 43:Issue 9(2013) Page Start: 979 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. SAFETY ANALYSIS OF AUSTRALASIAN LEUKAEMIA & LYMPHOMA GROUP NHL29: A PHASE II STUDY OF IBRUTINIB, RITUXIMAB AND MINI‐CHOP IN VERY ELDERLY PATIENTS WITH NEWLY DIAGNOSED DLBCL. (12th June 2019) Authors: Verner, E.K.; Johnston, A.J.; Pati, N.; Hawkes, E.; Lee, H.; Cochrane, T.; Cheah, C.Y.; Filshie, R.; Purtill, D.; Enjeti, A.K.; Brown, C.; Murphy, N.; Curnow, J.; Cake, S.; Carlson, J.; Butcher, B.E.; Trotman, J. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 254 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗